Rezzayo antifungal okayed as Candida auris rings alarm bells
Drug is first new echinocandin to be approved for marketing in the US in more than a decade.
Sanofi, Regeneron’s wager on Dupixent in COPD pays off
Approval in COPD could unlock a $3 billion market opportunity for the drug, say analysts.
FDA advisors split on Biogen’s ALS therapy
But unanimous vote on biomarker validity could support accelerated approval of tofersen.
Project seeks to shape digital health reimbursement in APAC
APACMed and Eversana join forces to draw up coverage frameworks applicable to APAC countries.
FDA rejects AbbVie’s continuous Parkinson’s therapy
Delay could narrow the gap between AbbVie's product and a rival system from Mitsubishi Tanabe.
Cell & Gene Therapy Summit 2023
Enabling market access, policy, and delivery 24th-25th April 2023, Brussels
Maximizing Insights At Congresses
In terms of gathering medical insights, congresses are unique for several reasons.
The Challenge Of Finding KOLs For Innovative Therapies
You have a truly innovative medicine with a unique proposition in an area with a clear unmet need
Social Health and Cancer as a Chronic Condition
Data demonstrates the critical role of social health for people living with and beyond cancer
Newel Health begins next phase of development of Soturi
Newel Health's Soturi, a DTx solution for Parkinson’s Disease, begins next phase.